The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 83, Issue 1, Pages 88-95
Publisher
Wiley
Online
2016-02-07
DOI
10.1111/bcp.12899
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silymarin alleviates hepatic oxidative stress and protects against metabolic disorders in high-fat diet-fed mice
- (2016) Bin Feng et al. FREE RADICAL RESEARCH
- Cardioprotective mechanism of omega-3 polyunsaturated fatty acids
- (2016) Jin Endo et al. Journal of Cardiology
- Effects of N-3 Fatty Acids on Hepatic Triglyceride Content in Humans
- (2016) Gloria Lena Vega et al. JOURNAL OF INVESTIGATIVE MEDICINE
- The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
- (2015) Forouzan Faghihzadeh et al. BRITISH JOURNAL OF NUTRITION
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- High-dose vitamin D supplementation and liver histology in NASH: Table 1
- (2015) Matthew T Kitson et al. GUT
- Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives
- (2015) Federico Salomone et al. LIVER INTERNATIONAL
- A CONSORT-Compliant, Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Purified Anthocyanin in Patients With Nonalcoholic Fatty Liver Disease
- (2015) Pei-Wen Zhang et al. MEDICINE
- Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
- (2015) Ken Sato et al. NUTRITION
- Properties of Resveratrol:In VitroandIn VivoStudies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
- (2015) J. Gambini et al. Oxidative Medicine and Cellular Longevity
- Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation
- (2015) Roberto Carnevale et al. THROMBOSIS AND HAEMOSTASIS
- Vitamin D: A new player in non-alcoholic fatty liver disease?
- (2015) Myrto Eliades WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study
- (2015) Gianpaolo Sorrentino et al. Drugs in research & development
- Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis
- (2015) Daniele Pastori et al. Clinical and Translational Gastroenterology
- NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease
- (2014) Maria Del Ben et al. BMC GASTROENTEROLOGY
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- n-3 PUFA Esterified to Glycerol or as Ethyl Esters Reduce Non-Fasting Plasma Triacylglycerol in Subjects with Hypertriglyceridemia: A Randomized Trial
- (2014) Anne Hedengran et al. LIPIDS
- Pharmacological potential of tocotrienols: a review
- (2014) Haseeb Ahsan et al. Nutrition & Metabolism
- Modern approach to the clinical management of non-alcoholic fatty liver disease
- (2014) Maria Del Ben WORLD JOURNAL OF GASTROENTEROLOGY
- Does Vitamin C Deficiency Promote Fatty Liver Disease Development?
- (2014) David Ipsen et al. Nutrients
- Involvement of free radicals and oxidative stress in NAFLD/NASH
- (2013) Y. Sumida et al. FREE RADICAL RESEARCH
- Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation
- (2013) Roberto Cangemi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
- (2013) Akinobu Takaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation of Vitamin C Homeostasis during Deficiency
- (2013) Maiken Lindblad et al. Nutrients
- Vitamin C Intake, Circulating Vitamin C and Risk of Stroke: A Meta‐Analysis of Prospective Studies
- (2013) Guo‐Chong Chen et al. Journal of the American Heart Association
- High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
- (2012) M. M. Poulsen et al. DIABETES
- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus
- (2012) Ilaria Barchetta et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Oral Tocotrienols Are Transported to Human Tissues and Delay the Progression of the Model for End-Stage Liver Disease Score in Patients
- (2012) Viren Patel et al. JOURNAL OF NUTRITION
- Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial
- (2011) V. Nobili et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes
- (2011) Ilaria Barchetta et al. BMC Medicine
- Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation
- (2011) Christian L. Roth et al. HEPATOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- l-Carnitine Supplementation to Diet: A New Tool in Treatment of Nonalcoholic Steatohepatitis—A Randomized and Controlled Clinical Trial
- (2010) Mariano Malaguarnera et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Serum 25-Hydroxy Vitamin D and Insulin Resistance, Metabolic Syndrome, and Glucose Intolerance Among Arab Americans
- (2010) N. R. Pinelli et al. DIABETES CARE
- Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study
- (2010) Francesco Sofi et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of carnitine in disease
- (2010) Judith L Flanagan et al. Nutrition & Metabolism
- Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
- (2010) Kanti Bhooshan Pandey et al. Oxidative Medicine and Cellular Longevity
- Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial
- (2009) Manal F. Abdelmalek et al. HEPATOLOGY
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
- (2008) Valerio Nobili et al. HEPATOLOGY
- Altered Hyperlipidemia, Hepatic Steatosis, and Hepatic Peroxisome Proliferator-Activated Receptors in Rats with Intake of Tart Cherry
- (2008) E. Mitchell Seymour et al. JOURNAL OF MEDICINAL FOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now